Merck challenges US government over Medicare drug pricing bill.
TL;DR Summary
Merck has filed a lawsuit challenging the constitutionality of the Inflation Reduction Act, which aims to reduce drug prices. The lawsuit claims that the bill violates the First and Fifth Amendments and is closer to extortion than negotiation. This move marks the pharma industry's opposition to the landmark drug pricing law.
- Merck sues US government over IRA, challenging drug pricing bill's constitutionality Endpoints News
- Merck sues Biden administration over Medicare drug price negotiations CNBC
- Merck Sues Over Medicare Drug-Price Negotiation Law The New York Times
- Merck sues US government to halt Medicare drug price negotiation Yahoo Finance
- Merck sues Biden HHS for drug price-fixing 'sham' it says would cripple pharmaceutical industry Fox Business
Reading Insights
Total Reads
0
Unique Readers
8
Time Saved
0 min
vs 1 min read
Condensed
56%
115 → 51 words
Want the full story? Read the original article
Read on Endpoints News